Thyroid arterial embolization to treat Graves' disease

Acta Radiol. 2007 Mar;48(2):186-92. doi: 10.1080/02841850601128967.

Abstract

Purpose: To prospectively investigate the effect of thyroid arterial embolization on hyperthyroid Graves' disease in selected patients.

Material and methods: Twenty-eight patients with hyperthyroidism caused by Graves' disease were enrolled to undergo thyroid arterial embolization and followed up for 12-22 months. Twenty-two patients had three thyroid arteries embolized and six patients two arteries. Serum thyroid hormone, thyroid-stimulating hormone (TSH), and autoimmune function were tested before and after embolization in all patients.

Results: Of 28 patients, 22 (78.6%) became euthyroid, five improved (17.8%), and one had temporary improvement followed by recurrence (3.6%). No serious complications occurred. Compared with the pre-embolization values, serum concentrations of thyroid hormone increased temporarily on day 3 post-embolization, dropped substantially after 1 and 2 months, and returned to nearly normal at 6 and 12 months post-embolization. TSH dropped on day 3, increased after 1 and 2 months, and returned to normal after 6 and 12 months. Thyroid antibodies TGAb and TMAb declined on day 3 to normal range, rose after 1 month, dropped to normal again after 2 months, and were slightly increased at 6 and 12 months follow-up.

Conclusion: Thyroid arterial embolization may be an effective approach for patients with hyperthyroidism caused by Graves' disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Angiography
  • Embolization, Therapeutic / methods*
  • Female
  • Graves Disease / diagnostic imaging
  • Graves Disease / therapy*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Thyroid Function Tests
  • Thyroid Gland / blood supply
  • Treatment Outcome
  • Ultrasonography, Doppler